Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cipla Ltd.
NSE: CIPLA
|
BSE: 500087
|
ISIN: INE059A01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
1399.2000
-2.70
(
-0.19
%)
NSE
May 22, 2026
15:31 PM
Volume:
917.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cipla Ltd.
16 May 2020
1399.20
-0.19%
Cipla (BUY): Adj. EBITDA in line; multiple stock catalysts BUY
Buy:
Cipla Ltd.
by
BOB Capital Markets Ltd.
Target: 690
Target
BOB Capital Markets Ltd.
Cipla reported in-line revenue but a 14% EBITDA miss in Q4.
Number of FII/FPI investors decreased from 1052 to 964 in Mar 2026 qtr
More from Cipla Ltd.
Recommended
Five Interesting Stocks Today - May 22, 2026
The Baseline |
22 May 2026
Market closes higher on hopes of a US-Iran peace deal
Trendlyne Marketwatch |
22 May 2026
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
|
20 May 2022